Skip to main content
letter
. 2020 May 16;72(3):218–219. doi: 10.1016/j.ihj.2020.05.003

Fig. 1.

Fig. 1

Possible hypothesis of pulmonary embolism in COVID-19. Cytokine surge secondary to viremia causes endothelial dysfunction. Presence of anti-β2 glycoprotein/antiphospholipid antibodies in COVID-19 could be a potential cause of pulmonary thrombosis. IL-1: Interleukin-1, IL-1β: Interleukin-1β, IL-6: Interleukin-6, Interferon-γ: Interferon-γ, and TNF-α:Tumor necrosis factor-α.